Pharmacy Report Archives - Page 42 of 154 - Becker's Hospital Review

Adverse event halts flu-COVID drug study | Pediatric cancer drug shortages: 5 notes | 10 systems seeking pharmacy leaders | 1st mRNA C. diff vaccine created at Penn Med | Pharmacy CEO convicted in $160M scheme

October 17, 2024 BHR Newsletter 1. Why hundreds of US pharmacies are closing Full story 2. Combination flu-COVID drug study paused after 'serious adverse event' Full story 3. Pediatric cancer drug shortage: 5 things to know Full story 4. Women's…

US moves to boost IV supplies: 5 updates | Texas system 3D-prints drugs | Pharmacies hesitant to sell CMS-negotiated drugs | 24 systems preferred 2-to-1 over competitors

October 16, 2024 BHR Newsletter 1. US invokes Defense Production Act amid IV shortage: 5 updates Full story 2. 20 tips for hospitals amid IV, peritoneal dialysis solution shortage Full story 3. 90% of independent pharmacies may not stock drugs…

Walgreens to close 1,200 stores: 6 notes | Baxter imports IV fluids | DSCSA enforcement delayed: 4 details | Pharmacist sentenced for role in meningitis outbreak | 4 healthcare exec pay trends

October 15, 2024 BHR Newsletter 1. Walgreens to close 1,200 stores: 6 notes Full story 2. Another DSCSA enforcement delay: 4 things to know Full story 3. 4 trends in healthcare executive pay Full story 4. Pharmacists are weighed down by…

IV shortage: CDC shares tips as systems ration | Compounded Mounjaro in limbo: 5 notes | CVS to end infusion services | Ex-hospital CEO charged in 45-count indictment

October 14, 2024 BHR Newsletter 1. CDC issues guidelines for IV, PD fluid shortage Full story 2. Health system strategies to mitigate the IV shortage: What to know Full story 3. 4 hospital expansions worth $1B or more Full story…

IV allocations rise: 6 updates | Pharmacist to lead Ore. hospital | GSK to settle Zantac suits for $2.2B | Hospitals + Milton: 9 notes | 2 Alzheimer's drugs show promise

October 10, 2024 BHR Newsletter 1. Baxter increases IV allocations: 6 shortage updates Full story 2. GSK agrees to settle 80,000 Zantac lawsuits for $2.2B Full story 3. Hospitals and Hurricane Milton: 9 things to know Full story 4. Find…

CMS' $2 drug price list: 5 notes | Pharmacists urge fed'l action as IV shipments resume | Mount Sinai exec joins Eli Lilly | Amazon Pharmacy to expand | GLP-1s may cost Medicare $35B by 2034: CBO

October 9, 2024 BHR Newsletter 1. CMS proposes $2 Medicare drug list: 5 things to know Full story 2. Eli Lilly snags chief AI officer from Mount Sinai Full story 3. Baxter resumes some IV shipments: 5 updates Full story…

FDA sued over Zepbound shortage end | Hospitals urge federal action on IV shortage | 10 notes on hospital pharmacies | CVS to lay off 632 | ChatGPT overprescribes in the ED: Study

October 8, 2024 BHR Newsletter 1. Trade group sues FDA for removing Eli Lilly weight loss drug from shortage list Full story 2. CVS to lay off 632 at Rhode Island headquarters Full story 3. The state of hospital pharmacies…

Hospitals prep for IV fluid shortages | The 73 drugs Baxter's NC site makes | Texas sues PBMs, drugmakers: 5 notes | Hospitals to CMS: Extend prescribing flexibilities | Zepbound shortage ends

October 7, 2024 BHR Newsletter 1. Hospitals prepare for months-long supply disruptions after Helene, port strike Full story 2. The 73 drugs made at Baxter's flooded site Full story 3. Kroger sells specialty pharmacy unit to Elevance Full story 4.…

After $40M settlement, drug trial continues | CMS edits drug price talks | 10 systems seeking pharmacy leaders | La. restricts abortion pill access | Ozempic as an addiction therapy: 4 notes

October 3, 2024 BHR Newsletter 1. CMS tweaks drug price negotiations for 2025 Full story 2. After $40M settlement, Alzheimer's drug under scrutiny as human trials proceed Full story 3. Ozempic as an addiction treatment: 4 notes Full story 4. Don't risk losing to…

CVS' potential breakup: 3 notes | Payer to offer $0 Humira biosimilar: 7 notes | Drug co. pays $40M to settle case | Mass. system exits bankruptcy | An overlooked drug for C. diff

October 2, 2024 BHR Newsletter 1. Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro Full story 2. Why a CVS breakup may be hard to execute: 3 notes Full story 3. Blue Shield of California's zero-dollar biosimilar strategy:…